A Systematic Approach to Design and Prepare Solid Dispersions of Poorly Water-Soluble Drug

No abstract is available for this paper.

• Publication year

  2014

• Venue

  AAPS PharmSciTech

• Publication date

  2014-02-22

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1208/s12249-014-0093-zPMID 24563175PMCID PMC4037479
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A thermal analysis method to predict the complete phase diagram of drug-polymer solid dispersions.

  2010cited by this paper
• Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram.

  2010cited by this paper
• Correlating thermodynamic and kinetic parameters with amorphous stability.

  2009influential reference
• Miscibility/stability considerations in binary solid dispersion systems composed of functional excipients towards the design of multi-component amorphous systems.

  2009cited by this paper
• Molecular Mobility and Physical Stability of Amorphous Irbesartan

  2009influential reference
• Enhancement of Oral Bioavailability of Cilostazol by Forming its Inclusion Complexes

  2009cited by this paper
• Estimation of Drug–Polymer Miscibility and Solubility in Amorphous Solid Dispersions Using Experimentally Determined Interaction Parameters

  2008cited by this paper
• Thermodynamic behavior of glassy state of structurally related compounds.

  2008cited by this paper
• In vitro-in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol.

  2008cited by this paper
• Entropy of Mixing and the Glass Transition of Amorphous Mixtures

  2008cited by this paper
• Micronization of cilostazol using supercritical antisolvent (SAS) process: Effect of process parameters

  2007cited by this paper
• Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs.

  2006cited by this paper
• Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.

  2006cited by this paper
• Theoretical and Practical Approaches for Prediction of Drug–Polymer Miscibility and Solubility

  2006influential reference
• Physicochemical evaluation of PVP-thiazide diuretic interactions in co-spray-dried composites--analysis of glass transition composition relationships.

  2005cited by this paper
• Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.

  2005influential reference
• Physics of amorphous solids.

  2004cited by this paper
• Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs

  2004cited by this paper
• Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms

  2004cited by this paper
• Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability

  2004cited by this paper
• Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility.

  2004influential reference
• Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug.

  2003cited by this paper
• Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability

  2003cited by this paper
• Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility.

  2002influential reference
• Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions.

  2002cited by this paper
• Formulation approaches for orally administered poorly soluble drugs.

  2002cited by this paper
• Polymorphic forms of cilostazol.

  2002cited by this paper
• Thermally-prepared polymorphic forms of cilostazol.

  2002cited by this paper
• Comparative effects of cilostazol and other therapies for intermittent claudication.

  2001cited by this paper
• Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions.

  2001cited by this paper
• Characterization of glassy itraconazole: a comparative study of its molecular mobility below T(g) with that of structural analogues using MTDSC.

  2001influential reference
• The use of thermal methods for predicting glass-former fragility

  2001cited by this paper
• Molecular mobility of amorphous pharmaceuticals determined using differential scanning calorimetry

  2001cited by this paper
• Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis.

  2001cited by this paper
• Physical characteristics and chemical degradation of amorphous quinapril hydrochloride.

  2000influential reference
• What is the True Solubility Advantage for Amorphous Pharmaceuticals?

  2000influential reference
• Disorder and twinning in molecular crystals: impurity-induced effects in adipic acid.

  2000cited by this paper
• Thermal and mechanical properties of poly(l-lactic acid)–poly (ethylene-co-vinyl acetate) blends

  1999cited by this paper
• The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems.

  1999cited by this paper
• Stability prediction of amorphous benzodiazepines by calculation of the mean relaxation time constant using the Williams-Watts decay function.

  1999influential reference
• The use of MTDSC to assess the amorphous phase content of a micronized drug substance.

  1999cited by this paper
• Solubility parameters as predictors of miscibility in solid dispersions.

  1999cited by this paper
• Solubility and Solubilization in Aqueous Media

  1999cited by this paper
• Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures.

  1998influential reference
• Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.

  1998cited by this paper
• The use of solubility parameters in pharmaceutical dosage form design

  1997cited by this paper
• Characteristics and significance of the amorphous state in pharmaceutical systems.

  1997cited by this paper
• Strong and fragile liquids — a brief critique

  1996cited by this paper
• Glass transitions and water-food structure interactions.

  1995cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995cited by this paper
• The old problems of glass and the glass transition, and the many new twists.

  1995cited by this paper
• Enthalpy relaxation and recovery in amorphous materials

  1994cited by this paper
• Relationship between the glass transition temperature and the interaction parameter of miscible binary polymer blends

  1992cited by this paper
• Relaxation in liquids, polymers and plastic crystals — strong/fragile patterns and problems☆

  1991cited by this paper
• Effect of hydrogen bonding on the enthalpy of mixing and the composition dependence of the glass transition temperature in polymer blends

  1991cited by this paper
• Thermodynamic aspects of the glass transition in liquids and plastic crystals

  1991cited by this paper
• Effect of cilostazol on platelet aggregation and experimental thrombosis.

  1985cited by this paper
• Physico-chemical properties and stability of cilostazol.

  1985cited by this paper
• Excess entropies and related quantities in glass-forming liquids

  1980cited by this paper
• The Nature of the Glassy State and the Behavior of Liquids at Low Temperatures.

  1948cited by this paper

• Development of novel ketoprofen hydrogels by introducing small molecular ligands for simultikaneous release and permeability enhancement

  2025cites this paper
• Innovative buccal film delivery system for hypertension: Combining candesartan and hydrochlorothiazide

  2025cites this paper
• Design of indomethacin novel small molecule hydrogels for concomitant release and permeability increases.

  2025cites this paper
• Systematic Development of Hot Melt Extrusion-Based Amorphous Solid Dispersion: Integrating Quality by Design and In Silico Modeling

  2024influential citation
• Characterization and Dissolution Mechanism of Low-Molecular-Weight Organic Acids or Inorganic Mesoporous Particle-Based Piperine Amorphous Solid Dispersions.

  2024cites this paper
• Utilizing Drug Amorphous Solid Dispersions for the Preparation of Dronedarone per os Formulations

  2023influential citation
• Hot “Dissolving” Extrusion of Lurasidone with Natural Liquid Small Molecule for Amorphous Solid Dispersion Based Self‐Assembled Submicron Emulsion

  2023cites this paper
• A prediction system: regulating effect of small-molecule additives on properties of amorphous solid dispersions prepared by hot-melt extrusion technology.

  2023cites this paper
• Development of the Composition and Technology for Production a Solid Dispersion System by Hot Melt Extrusion to Increase the Bioavailability of the Active Substance

  2022cites this paper
• состава и технологии получения

  2022cites this paper
• PEG- 4000 increases solubility and dissolution rate of vinpocetin in solid dispersion system

  2022cites this paper
• Considerations for the Selection of Co-formers in the Preparation of Co-amorphous Formulations.

  2021cites this paper
• Influence of Plasdone™ S630 Ultra—an Improved Copovidone on the Processability and Oxidative Degradation of Quetiapine Fumarate Amorphous Solid Dispersions Prepared via Hot-Melt Extrusion Technique

  2021cites this paper
• Hot-Melt Extrusion: a Roadmap for Product Development

  2021cites this paper
• Quaternary enteric solid dispersion prepared by hot-melt extrusion to mask the bitter taste and enhance drug stability.

  2021cites this paper
• Fabrication and evaluation of fast disintegrating pellets of cilostazol

  2020cites this paper
• Predicting Density of Amorphous Solid Materials Using Molecular Dynamics Simulation

  2020cites this paper
• NMR and thermal studies for the characterization of mass transport and phase separation in paracetamol/copovidone hot-melt extrusion formulations.

  2020cites this paper
• Binary Amorphous Solid Dispersion:Method and Application

  2020cites this paper
• Polymer structure and property effects on solid dispersions with haloperidol: poly(N-vinyl pyrrolidone) and poly(2-oxazolines) studies.

  2020cites this paper
• Quality-by-design in hot melt extrusion based amorphous solid dispersions: An industrial perspective on product development.

  2020cites this paper
• Hot-melt extrusion in the pharmaceutical industry: toward filing a new drug application.

  2019cites this paper
• Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.

  2019cites this paper
• The Effect of Carrier Matrix and the Method of Preparing Solid Dispersion on Physical State and Solubility of Ibuprofen

  2019cites this paper
• Investigation of Drug–Polymer Miscibility and Solubilization on Meloxicam Binary Solid Dispersion

  2019cites this paper
• Modeling and Prediction of Amorphous Solid Dispersion Formation Using a Molecular Descriptor

  2019influential citation
• A 5-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.

  2019cites this paper
• Stabilisation and Growth of Metastable Form II of Fluconazole in Amorphous Solid Dispersions

  2019cites this paper
• SOLUBILITY AND BIOAVAILABILITY ENHANCEMENT STRATEGIES FOR EFFECTIVE DELIVERY OF POORLY WATER SOLUBLE DRUGS BY NANO FORMULATIONS AND SOLID DISPERSIONS

  2018cites this paper
• Amorphous Sol id Dispers ions : a Physicochemical Perspective with Thermodynamic , Kinetic and Environmental Aspects

  2018cites this paper
• Cilostazol-Loaded Poly(ε-Caprolactone) Electrospun Drug Delivery System for Cardiovascular Applications

  2018cites this paper
• The Application of Modeling and Prediction to the Formation and Stability of Amorphous Solid Dispersions.

  2018cites this paper
• PEG 8000 increases solubility and dissolution rate of quercetin in solid dispersion system

  2018cites this paper
• Development and Characterization of Solid Self-emulsifying Drug Delivery System Containing Nateglinide

  2017cites this paper
• Characterization, Molecular Docking, and In Vitro Dissolution Studies of Solid Dispersions of 20(S)-Protopanaxadiol

  2017cites this paper
• Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions.

  2017cites this paper
• Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.

  2016cites this paper
• Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium.

  2016cites this paper
• Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.

  2015cites this paper
• Effervescence Assisted Fusion Technique to Enhance the Solubility of Drugs

  2015cites this paper
• Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug

  2015cites this paper
• Self emulsifying drug delivery system for enhanced solubility and dissolution of glipizide.

  2015cites this paper
• Disintegration Mediated Controlled Release Supersaturating Solid Dispersion Formulation of an Insoluble Drug: Design, Development, Optimization, and In Vitro Evaluation

  2015cites this paper